Ask AI
ProCE Banner Series

VEXAS Syndrome Revealed: What HCPs Need to Know to Recognize and Effectively Manage Patients With Hemato-Inflammatory Clinical Manifestations

VEXAS syndrome can remain unrecognized for years as its complex inflammatory, hematologic, dermatologic, and pulmonary manifestations mimic more familiar disorders, delaying diagnosis and appropriate care. In this expert-led education, explore when to suspect VEXAS syndrome, the role of UBA1 testing and multidisciplinary evaluation, and evolving treatment strategies for this serious hemato-inflammatory disease.

  AAPA
  | AMA
  | ANCC
Who Should Attend

This activity is intended for rheumatologists, dermatologists, hematologists, nurse practitioners, and physician associates who manage patients with hemato-inflammatory clinical manifestations.

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this educational program is to improve learners’ knowledge, confidence, and competence regarding identification and management of patients with VEXAS syndrome.

Target Audience
This activity is intended for rheumatologists, dermatologists, hematologists, nurse practitioners, and physician associates who manage patients with hemato-inflammatory clinical manifestations.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain the pathophysiology of VEXAS syndrome to patients and colleagues

  • Identify and diagnose patients with unexplained hemato-inflammatory manifestations who may have VEXAS syndrome

  • Collaborate with others on the multidisciplinary team caring for patients with VEXAS syndrome to align treatment with evolving best practices and improve outcomes

  • Develop strategies to integrate evolving approaches for VEXAS syndrome into clinical practice to improve patient outcomes and quality of life

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by Sobi, Inc.

Sobi, Inc.

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191